Publication|Articles|December 18, 2024
- Pharmaceutical Executive: December 2024
- Volume 44
- Issue 12
Pharmaceutical Executive: December 2024 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive December 2024 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 1 year ago
Trending Forwardabout 1 year ago
Pharma’s ‘Best-Kept Secret’about 1 year ago
Seeking More Value, Less Costabout 1 year ago
Dealmaking Dormant No Moreabout 1 year ago
A Rocky Road for Regulationabout 1 year ago
DTC's New Era of Engagementabout 1 year ago
Holding On Tight to AI Waveabout 1 year ago
The Recipe for Relief: Overcoming Industry Pain Pointsabout 1 year ago
Pharma Forecasting: Key Markets Investors Can’t Ignoreabout 1 year ago
Introducing Agentic AI: Its Revolutionary Potential in PharmaNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
JP Morgan 2026: AbbVie Advances its Pipeline
2
Pharmaceutical Executive Daily: 2026 J.P. Morgan Healthcare Conference Coverage
3
Pharmaceutical Executive Daily: Continued Coverage of the 2026 J.P. Morgan Healthcare Conference
4
JP Morgan 2026: Novavax Shifting Towards Partnership-Driven Strategy
5